Xm. Chen et al., Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogenreceptor-negative breast cancer cells, J NAT CANC, 92(17), 2000, pp. 1403-1413
Background: Estrogen stimulates the proliferation of cells in normal mammar
y glands and most estrogen receptor (ER)positive mammary carcinomas by bind
ing to the ER and promoting the transcription of ER-responsive genes. In ce
lls with functional ERs, estrogen mediates the transition of cells from the
G(1) to S phase of the cell cycle. Several cell cycle regulatory proteins
have been implicated in the ER-signaling pathway involved in estrogen-media
ted growth stimulation and antiestrogen-mediated growth arrest, We sought t
o determine whether p21, a cyclin-dependent kinase inhibitor, is a componen
t of this pathway and, if so, whether it can mediate estrogen's action in E
R-negative breast cancer cells. Methods: We overexpressed p21 with a tetrac
ycline-inducible system in ER-negative, p21-negative breast cancer cells. A
ctivity of the ER-signaling pathway was monitored in transient transfection
assays by using constructs in which the ER promoter or the estrogen-respon
se element (ERE) controls Luciferase expression. The growth-modulating effe
cts of estradiol and antiestrogens on p21-overexpressing clones were assess
ed. All P values are from two-sided tests. Results: A strong positive assoc
iation was found between the expression of p21 and ER in nine breast cancer
cell lines and in tumor samples from 60 patients with breast cancer (P<.00
1). Overexpression of p21 in a p21-negative, ER-negative cell line induced
both the ER and ERE promoters in an estrogen-responsive manner. Last, stabl
e p21 clones that also lack the expression of wild-type ER were responsive
to the growth-inhibitory effects of ICI 182,780, a potent antiestrogen, and
the growth-stimulatory effects of 17 beta-estradiol, Conclusion: The abili
ty of p21 to mediate the activation of the estrogen-signaling pathway in ER
-negative tumor cells suggests that p21 plays a novel role in this pathway,
a finding that also has important clinical implications.